Xu Y - Search Results

1

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.

Xu Y, Peng Z, Li Z, Lu M, Gao J, Li Y, Li Y, Shen L. Xu Y, et al. BMC Cancer. 2015 Jan 15;15:6. doi: 10.1186/s12885-014-1001-3. BMC Cancer. 2015. PMID: 25588551 Free PMC article.

2

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis.

Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. Sun J, et al. Among authors: xu h, xu y. BMC Cancer. 2013 Dec 5;13:577. doi: 10.1186/1471-2407-13-577. BMC Cancer. 2013. PMID: 24304886 Free PMC article. Review.

3

Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?

Gao P, Song YX, Sun JX, Chen XW, Xu YY, Zhao JH, Huang XZ, Xu HM, Wang ZN. Gao P, et al. BMC Cancer. 2014 Nov 27;14:888. doi: 10.1186/1471-2407-14-888. BMC Cancer. 2014. PMID: 25428401 Free PMC article.

4

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.

Song Y, Yang Y, Gao P, Chen X, Yu D, Xu Y, Zhao J, Wang Z. Song Y, et al. Among authors: xu y. BMC Cancer. 2017 Nov 10;17(1):744. doi: 10.1186/s12885-017-3752-0. BMC Cancer. 2017. PMID: 29126400 Free PMC article.

5

Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.

Miao ZF, Liu XY, Wang ZN, Zhao TT, Xu YY, Song YX, Huang JY, Xu H, Xu HM. Miao ZF, et al. BMC Cancer. 2018 Jan 31;18(1):118. doi: 10.1186/s12885-018-4027-0. BMC Cancer. 2018. PMID: 29385994 Free PMC article. Review.

6

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis.

Li WY, Zhao TT, Xu HM, Wang ZN, Xu YY, Han Y, Song YX, Wu JH, Xu H, Yin SC, Liu XY, Miao ZF. Li WY, et al. Among authors: xu yy, xu hm, xu h. BMC Cancer. 2019 Feb 13;19(1):145. doi: 10.1186/s12885-019-5331-z. BMC Cancer. 2019. PMID: 30760227 Free PMC article.

7

Pyrotinib combined with CDK4/6 inhibitor in HER2-positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients.

Chen Z, Xu Y, Gong J, Kou F, Zhang M, Tian T, Zhang X, Zhang C, Li J, Li Z, Lai Y, Zou J, Zhu X, Gao J, Shen L. Chen Z, et al. Among authors: xu y. Clin Transl Med. 2020 Aug;10(4):e148. doi: 10.1002/ctm2.148. Clin Transl Med. 2020. PMID: 32898333 Free PMC article.

8

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.

Xu Y, Wang Y, Gong J, Zhang X, Peng Z, Sheng X, Mao C, Fan Q, Bai Y, Ba Y, Jiang D, Yang F, Qi C, Li J, Wang X, Zhou J, Lu M, Cao Y, Yuan J, Liu D, Wang Z, Fang J, Shen L. Xu Y, et al. Gastric Cancer. 2021 Jul;24(4):913-925. doi: 10.1007/s10120-021-01168-7. Epub 2021 May 4. Gastric Cancer. 2021. PMID: 33945049 Free PMC article. Clinical Trial.

9

From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression.

Chen Z, Yuan J, Xu Y, Zhang C, Li Z, Gong J, Li Y, Shen L, Gao J. Chen Z, et al. Among authors: xu y. Front Pharmacol. 2022 Jan 5;12:757994. doi: 10.3389/fphar.2021.757994. eCollection 2021. Front Pharmacol. 2022. PMID: 35069192 Free PMC article.

10

Clinicopathological significance of claudin-4 in gastric carcinoma.

Zhu JL, Gao P, Wang ZN, Song YX, Li AL, Xu YY, Wang MX, Xu HM. Zhu JL, et al. World J Surg Oncol. 2013 Jul 4;11:150. doi: 10.1186/1477-7819-11-150. World J Surg Oncol. 2013. PMID: 23822740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,089 results

Search Page

Filters